LabCorp continues to strengthen its position in
bio-tech sector through a variety of strategic moves and financial performance. The company is slated to host an Investor Day on September 14, 2023, and to present its strategic, business, and financial outlook. Despite facing some margin pressure, LabCorp's Oncology arm has managed to gain enough traction over time. The company has seen variety of changes, including a cosmetic one and exciting acquisitions like select assets of Invitae and BioReference Health's diagnostics business. The results of its
2024 First Quarter were announced and were followed by a
dividend announcement of $0.72 per share. The
Oracle Cerner Technology will manage hospital labs across 10 states. Despite some missed earnings estimates, LabCorp retains investor confidence. Long-term value investors find LabCorp attractive due to significant innovation in its service expansion and positive performance over a five-year period with 67% increase. LabCorp also enjoys significant investor attention as evident with Nomura Asset Management Co., Ltd., Bank of Nova Scotia, and Stifel Financial Corp amplify their stake in the company.
Laboratory Corporation of America Holdings LH News Analytics from Mon, 03 Jul 2023 07:00:00 GMT to Sun, 02 Jun 2024 11:50:11 GMT -
Rating 6
- Innovation 8
- Information 7
- Rumor -3
